New antiviral treatment for COVID-19 will be mostly set aside for use in older unvaccinated individuals and immunocompromised Ontarians
A new antiviral drug that can be used to treat COVID-19 will be primarily set aside for use in older unvaccinated individuals and immunocompromised Ontarians.
The Ford government has released new eligibility guidelines that provide the first look at how it will distribute its limited supply of Pfizer’s Paxlovid pill, the first shipment of which arrived in the province last week.
The government says that it is prioritizing individuals at “the highest risk of severe outcomes,” including unvaccinated Ontarians age 60 and up and unvaccinated Ontarians aged 50 and up who also have one or more specific risk factors.
The government will also make all immunocompromised individuals aged 18 and up eligible, regardless of their vaccination status, as well as all unvaccinated First Nation, Inuit and Métis individuals aged 50 and up.
In order to access the drug those eligible will have to first test positive for COVID-19 and the Ford government says that it is now introducing “expanded COVID-19 assessment centres” where Ontarians will be able to access both testing and “outpatient therapeutics,” such as Paxlovid.
It says that the testing centres will have access to multiple testing options, including rapid tests, to asses those who may be eligible for treatment.
However, not all assessment centres will have the drug on hand.
According to data from the clinical trials, the Paxlovid pill was found to be 89 per cent effective at reducing the risk of hospitalization and death after a full course of treatment (three pills twice daily for five days in a row).
The Ontario government has said that it expects to receive approximately 10,000 courses of treatment in January.
“Given the very limited supply of antivirals, not all patients who meet the clinical eligibility criteria will be guaranteed access to treatment,” the government warns on a new website set up to provide information about antiviral treatments.
Paxlovid was approved by Health Canada on Jan. 17.
CTVNews.ca Top Stories
Solar storm puts on brilliant light show across the globe, but no serious problems reported
A powerful solar storm put on an amazing skyward light show across the globe overnight but has caused what appeared to be only minor disruptions to the electric power grid, communications and satellite positioning systems.
Potentially toxic chemicals hide in our drinking water and countless household objects, and they're not going anywhere
For decades, North Bay, Ontario's water supply has harboured chemicals associated with liver and developmental issues, cancer and complications with pregnancy. It's far from the only city with that problem.
Suspect sought after fatal slashing in downtown Toronto
Police are searching for a suspect in a homicide investigation after a man was slashed in downtown Toronto on Sunday.
'It was violent': Police tear down U of A pro-Palestinian encampment Saturday morning
Multiple people at the protest camp torn down at the University of Alberta campus Saturday say police's actions against protesters were "violent" and "disproportionate."
'My family doctor just fired me': Ontario patients frustrated with de-rostering
Dozens of Ontarians are expressing frustration in the province’s health-care system after their family doctors either dropped them as patients or threatened to after they sought urgent care elsewhere.
Canada Post cracks down on Nunavut loophole to get free Amazon Prime shipping
Amazon's paid subscription service provides free delivery for online shopping across Canada except for remote locations, the company said in an email. While customers in Iqaluit qualify for the offer, all other communities in Nunavut are excluded.
Nigeria's fashion and dancing styles in the spotlight as Harry, Meghan visit its largest city
Nigeria's fashion and traditional dances were at full display on Sunday as Prince Harry and Meghan arrived in its largest city, Lagos, as part of their three-day visit to the country to promote mental health for soldiers and empower young people.
Montreal man facing charges following contraband drone drop at Millhaven: OPP
The Ontario Provincial Police (OPP) says a 40-year-old man from Montreal is facing charges following a suspected drone drop of unauthorized items at the Millhaven Institution.
Blinken delivers some of the strongest U.S. public criticism of Israel's conduct of the war in Gaza
Secretary of State Antony Blinken on Sunday delivered some of the Biden administration's strongest public criticism yet of Israel's conduct of the war in Gaza, saying Israeli tactics have meant "a horrible loss of life of innocent civilians" but failed to neutralize Hamas leaders and fighters and could drive a lasting insurgency.